(Q41108923)

26 September 2017

Membrane-anchored heparin-binding epidermal growth factor-like growth factor acts as a tumor survival factor in a hepatoma cell line (English)

1 reference

26 September 2017

hepatocellular carcinoma

1 reference

Miyoshi E

1

1 reference

26 September 2017

Higashiyama S

2

1 reference

26 September 2017

Nakagawa T

3

1 reference

26 September 2017

Hayashi N

4

1 reference

26 September 2017

Taniguchi N

5

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

Journal of Biological Chemistry

26 September 2017

1 reference

26 September 2017

272

1 reference

26 September 2017

22

1 reference

26 September 2017

14349-14355

1 reference

A Heparin-Binding Growth Factor Secreted by Macrophage-Like Cells That Is Related to EGF

26 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Tissue distribution of mRNA for heparin-binding epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

High expression of heparin-binding EGF-like growth factor in rat hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients*

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Molecular regulation of apoptosis: genetic controls on cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Toxic metabolites released from rat hepatoma cells in culture. I. Effects of metabolites of hepatomas on various cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Heparin-binding EGF-like growth factor: characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Juxtacrine cell signaling molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Variation in EGF-induced EGF receptor downregulation in human hepatoma-derived cell lines expressing different amounts of EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.22.14349

21 January 2018

Identifiers

DOI

10.1074/JBC.272.22.14349

1 reference

26 September 2017

1 reference